Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

Name: Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
License: Public Domain

Beijing Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type 2 diabetic patients, t2dm (type 2 diabetes mellitus), t2dm

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429678
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.